Late-life personality traits, cognitive impairment, and mortality in a population-based cohort.

anger anxiety cognitive impairment dementia epidemiology sense of coherence

Journal

International journal of geriatric psychiatry
ISSN: 1099-1166
Titre abrégé: Int J Geriatr Psychiatry
Pays: England
ID NLM: 8710629

Informations de publication

Date de publication:
09 2020
Historique:
received: 21 01 2020
revised: 21 04 2020
accepted: 25 04 2020
pubmed: 5 5 2020
medline: 4 3 2021
entrez: 5 5 2020
Statut: ppublish

Résumé

We examined longitudinal associations between late-life personality traits and cognitive impairment, dementia, and mortality in the population-based Cardiovascular Risk Factors, Aging and Dementia (CAIDE) Study. Anger expression and trait anger (State-Trait Anger Expression Inventory), anxiety (State-Trait Anxiety Inventory), and sense of coherence (Sense of Coherence Scale) were assessed at the 1998 CAIDE visit (1266 cognitively normal individuals, mean age 71.0 years). Totally, 582 participants had complete re-examination in 2005-2008 (105 mild cognitive impairment, MCI; and 29 dementia). National registers data until 2008 were also used for both participants and nonparticipants to ascertain incident dementia (96 cases) and mortality (227 died). Analyses were adjusted for age, sex, education, follow-up time, cardiovascular and lifestyle factors, and depressive symptoms. Higher anxiety was associated with higher risk of MCI/dementia (OR 1.68, 95% CI 1.07-2.63) and death (HR 1.46, 95% CI 1.08-1.98). High sense of coherence was associated with lower mortality (HR 0.65, 95% CI 0.45-0.93). These associations were attenuated after accounting for depressive symptoms (OR 1.57, 95% CI 0.96-2.58 for anxiety-MCI/dementia; HR 1.35, 95% CI 0.97-1.86 for anxiety-mortality; and HR 0.68, 95% CI 0.45-1.04 for sense of coherence-mortality). Trait anger was associated with higher dementia risk even after adjustments (HR 1.90, 95% CI 1.14-3.18). Anxiety was linked to worse cognitive outcome and mortality and sense of coherence to lower mortality. Depressive symptoms attenuated the associations. As a novel finding, trait anger was connected to dementia risk. These findings emphasize the importance of personality-related risk factors for dementia and mortality. J Am Geriatr Soc 68:-, 2020.

Identifiants

pubmed: 32363652
doi: 10.1002/gps.5321
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

989-999

Informations de copyright

© 2020 The Authors. International Journal of Geriatric Psychiatry published by John Wiley & Sons Ltd.

Références

Norton S, Matthews FE, Barnes DE, Yaffe K, Brayne C. Potential for primary prevention of Alzheimer's disease: an analysis of population-based data. Lancet Neurol. 2014;13(8):788-794.
Johansson L, Guo X, Duberstein PR, et al. Midlife personality and risk of Alzheimer disease and distress: a 38-year follow-up. Neurology. 2014;83(17):1538-1544.
Low L, Harrison F, Lackersteen SM. Does personality affect risk for dementia? A systematic review and meta-analysis. Am J Geriatr Psychiatry. 2013;21(8):713-728.
Terracciano A, Sutin AR, An Y, et al. Personality and risk of Alzheimer's disease: new data and meta-analysis. Alzheimers Dement. 2014;10(2):179-186.
Terracciano A, Stephan Y, Luchetti M, Albanese E, Sutin AR. Personality traits and risk of cognitive impairment and dementia. J Psychiatr Res. 2017;89:22-27.
Nishita Y, Tange C, Tomida M, Otsuka R, Ando F, Shimokata H. Personality and global cognitive decline in Japanese community-dwelling elderly people: a 10-year longitudinal study. J Psychosom Res. 2016;91:20-25.
Wilson RS, Arnold SE, Schneider JA, Kelly JF, Tang Y, Bennett DA. Chronic psychological distress and risk of Alzheimer's disease in old age. Neuroepidemiology. 2006;27(3):143-153.
Wilson RS, Begeny CT, Boyle PA, Schneider JA, Bennett DA. Vulnerability to stress, anxiety, and development of dementia in old age. Am J Geriatr Psychiatry. 2011;19(4):327-334.
Gulpers B, Ramakers I, Hamel R, Kohler S, Oude Voshaar R, Verhey F. Anxiety as a predictor for cognitive decline and dementia: a systematic review and meta-analysis. Am J Geriatr Psychiatry. 2016;24(10):823-842.
Jokela M, Batty GD, Nyberg ST, et al. Personality and all-cause mortality: individual-participant meta-analysis of 3,947 deaths in 76,150 adults. Am J Epidemiol. 2013;178(5):667-675.
Chapman BP, Fiscella K, Kawachi I, Duberstein PR. Personality, socioeconomic status, and all-cause mortality in the United States. Am J Epidemiol. 2010;171(1):83-92.
Iwasa H, Masui Y, Gondo Y, Inagaki H, Kawaai C, Suzuki T. Personality and all-cause mortality among older adults dwelling in a Japanese community: a five-year population-based prospective cohort study. Am J Geriatr Psychiatry. 2008;16(5):399-405.
Miloyan B, Bulley A, Bandeen-Roche K, Eaton WW, Goncalves-Bradley DC. Anxiety disorders and all-cause mortality: systematic review and meta-analysis. Soc Psychiatry Psychiatr Epidemiol. 2016;51(11):1467-1475.
Julius M, Harburg E, Cottington EM, Johnson EH. Anger-coping types, blood pressure, and all-cause mortality: a follow-up in Tecumseh, Michigan (1971-1983). Am J Epidemiol. 1986;124(2):220-233.
Wilson RS, Bienias JL, Mendes de Leon CF, Evans DA, Bennett DA. Negative affect and mortality in older persons. Am J Epidemiol. 2003;158(9):827-835.
Boeckxstaens P, Vaes B, De Sutter A, et al. A high sense of coherence as protection against adverse health outcomes in patients aged 80 years and older. Ann Fam Med. 2016;14(4):337-343.
Super S, Verschuren WM, Zantinge EM, Wagemakers MA, Picavet HS. A weak sense of coherence is associated with a higher mortality risk. J Epidemiol Community Health. 2014;68(5):411-417.
Sutin AR, Stephan Y, Terracciano A. Psychological well-being and risk of dementia. Int J Geriatr Psychiatry. 2018;33(5):743-747.
Sutin AR, Stephan Y, Terracciano A. Psychological distress, self-beliefs, and risk of cognitive impairment and dementia. J Alzheimers Dis. 2018;65(3):1041-1050.
Neuvonen E, Rusanen M, Solomon A, et al. Late-life cynical distrust, risk of incident dementia, and mortality in a population-based cohort. Neurology. 2014;82(24):2205-2212.
Ismail Z, Gatchel J, Bateman DR, et al. Affective and emotional dysregulation as pre-dementia risk markers: exploring the mild behavioral impairment symptoms of depression, anxiety, irritability, and euphoria. Int Psychogeriatr. 2018;30(2):185-196.
Kivipelto M, Helkala EL, Hänninen T, et al. Midlife vascular risk factors and late-life mild cognitive impairment: a population-based study. Neurology. 2001;56(12):1683-1689.
Folstein MF, Folstein SE, McHugh PR. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12(3):189-198.
Morris JC, Heyman A, Mohs RC, et al. The consortium to establish a registry for Alzheimer's disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer's disease. Neurology. 1989;39(9):1159-1165.
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: American Psychiatric Association; 1994.
McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology. 1984;34(7):939-944.
Petersen RC, Smith GE, Ivnik RJ, et al. Apolipoprotein E status as a predictor of the development of Alzheimer's disease in memory-impaired individuals. JAMA. 1995;273(16):1274-1278.
Solomon A, Ngandu T, Soininen H, Hallikainen MM, Kivipelto M, Laatikainen T. Validity of dementia and Alzheimer's disease diagnoses in Finnish national registers. Alzheimers Dement. 2014;10(3):303-309.
Spielberger CD. Manual for the State-Trait Anger Expression Inventory (STAXI). Odessa, FL: Psychological Assessment Resources; 1988.
Spielberger CD, Reheiser EC, Sydeman SJ. Measuring the experience, expression, and control of anger. Issues Compr Pediatr Nurs. 1995;18(3):207-232.
Forgays DG, Forgays DK, Spielberger CD. Factor structure of the State-Trait Anger Expression Inventory. J Pers Assess. 1997;69(3):497-507.
Marteau TM, Bekker H. The development of a six-item short-form of the state scale of the Spielberger State-Trait Anxiety Inventory (STAI). Br J Clin Psychol. 1992;31(Pt 3):301-306.
Tluczek A, Henriques JB, Brown RL. Support for the reliability and validity of a six-item state anxiety scale derived from the State-Trait Anxiety Inventory. J Nurs Meas. 2009;17(1):19-28.
Antonovsky A. Unraveling the Mystery of Health: How People Manage Stress and Stay Well. San Francisco, CA: Jossey-Bass; 1987.
Antonovsky A. The structure and properties of the sense of coherence scale. Soc Sci Med. 1993;36(6):725-733.
Eriksson M, Lindström B. Antonovsky's sense of coherence scale and the relation with health: a systematic review. J Epidemiol Community Health. 2006;60(5):376-381.
Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry. 1961;4:561-571.
Vartiainen E, Laatikainen T, Peltonen M, Puska P. Predicting coronary heart disease and stroke: the FINRISK calculator. Glob Heart. 2016;11(2):213-216.
Costa PT, McCrae RR. Revised NEO Personality Inventory (NEOPI-R) and NEO Five-Factor Inventory (NEO-FFI) Professional Manual. Odessa, FL: Psychological Assessment Resources; 1992.
Rodrigues R, Petersen RB, Perry G. Parallels between major depressive disorder and Alzheimer's disease: role of oxidative stress and genetic vulnerability. Cell Mol Neurobiol. 2014;34(7):925-949.
Cherbuin N, Kim S, Anstey KJ. Dementia risk estimates associated with measures of depression: a systematic review and meta-analysis. BMJ Open. 2015;5(12).e008853.
Cuijpers P, Vogelzangs N, Twisk J, Kleiboer A, Li J, Penninx BW. Differential mortality rates in major and subthreshold depression: meta-analysis of studies that measured both. Br J Psychiatry. 2013;202(1):22-27.
Abraham S, Shah NG, Diez Roux A, et al. Trait anger but not anxiety predicts incident type 2 diabetes: the Multi-Ethnic Study of Atherosclerosis (MESA). Psychoneuroendocrinology. 2015;60:105-113.
Smith TW, Glazer K, Ruiz JM, Gallo LC. Hostility, anger, aggressiveness, and coronary heart disease: an interpersonal perspective on personality, emotion, and health. J Pers. 2004;72(6):1217-1270.
Suls J. Anger and the heart: perspectives on cardiac risk, mechanisms and interventions. Prog Cardiovasc Dis. 2013;55(6):538-547.
McSherry WC, Holm JE. Sense of coherence: its effects on psychological and physiological processes prior to, during, and after a stressful situation. J Clin Psychol. 1994;50(4):476-487.
Russ TC, Stamatakis E, Hamer M, Starr JM, Kivimäki M, Batty GD. Association between psychological distress and mortality: individual participant pooled analysis of 10 prospective cohort studies. BMJ. 2012;345:e4933.
Wainwright NWJ, Surtees PG, Welch AA, Luben RN, Khaw K, Bingham SA. Healthy lifestyle choices: could sense of coherence aid health promotion?J Epidemiol Community Health. 2007;61(10):871-876.
Anyfantakis D, Symvoulakis EK, Linardakis M, Shea S, Panagiotakos D, Lionis C. Effect of religiosity/spirituality and sense of coherence on depression within a rural population in Greece: the Spili III project. BMC Psychiatry. 2015;15:173-173.
Hänninen T, Hallikainen M, Tuomainen S, Vanhanen M, Soininen H. Prevalence of mild cognitive impairment: a population-based study in elderly subjects. Acta Neurol Scand. 2002;106(3):148-154.
Hou XH, Feng L, Zhang C, Cao XP, Tan L, Yu JT. Models for predicting risk of dementia: a systematic review. J Neurol Neurosurg Psychiatry. 2019;90(4):373-379.

Auteurs

Elisa Neuvonen (E)

Institute of Clinical Medicine/Neurology, School of Medicine, University of Eastern Finland, Kuopio, Finland.

Anette Hall (A)

Institute of Clinical Medicine/Neurology, School of Medicine, University of Eastern Finland, Kuopio, Finland.

Anna-Maija Tolppanen (AM)

Research Centre for Comparative Effectiveness and Patient Safety, University of Eastern Finland, Kuopio, Finland.
School of Pharmacy, University of Eastern Finland, Kuopio, Finland.

Tiia Ngandu (T)

Public Health Promotion Unit, Department of Public Health Solutions, National Institute for Health and Welfare, Helsinki, Finland.
Division of Clinical Geriatrics, Department of Neurobiology, Care Sciences, and Society, Karolinska Institutet, Stockholm, Sweden.

Minna Rusanen (M)

Institute of Clinical Medicine/Neurology, School of Medicine, University of Eastern Finland, Kuopio, Finland.
Public Health Promotion Unit, Department of Public Health Solutions, National Institute for Health and Welfare, Helsinki, Finland.
Neurocenter, Department of Neurology, Kuopio University Hospital, Kuopio, Finland.

Tiina Laatikainen (T)

Public Health Promotion Unit, Department of Public Health Solutions, National Institute for Health and Welfare, Helsinki, Finland.
Institute of Public Health and Clinical Nutrition, School of Medicine, University of Eastern Finland, Kuopio, Finland.
Joint Municipal Authority for North Karelia Social and Health Services (Siun sote), Joensuu, Finland.

Hilkka Soininen (H)

Institute of Clinical Medicine/Neurology, School of Medicine, University of Eastern Finland, Kuopio, Finland.
Neurocenter, Department of Neurology, Kuopio University Hospital, Kuopio, Finland.

Miia Kivipelto (M)

Institute of Clinical Medicine/Neurology, School of Medicine, University of Eastern Finland, Kuopio, Finland.
Division of Clinical Geriatrics, Department of Neurobiology, Care Sciences, and Society, Karolinska Institutet, Stockholm, Sweden.
Institute of Public Health and Clinical Nutrition, School of Medicine, University of Eastern Finland, Kuopio, Finland.
Ageing Epidemiology (AGE) Research Unit, School of Public Health, Imperial College London, London, UK.

Alina Solomon (A)

Institute of Clinical Medicine/Neurology, School of Medicine, University of Eastern Finland, Kuopio, Finland.
Division of Clinical Geriatrics, Department of Neurobiology, Care Sciences, and Society, Karolinska Institutet, Stockholm, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH